Oxamate Nanoparticles for Enhanced Tumor Immunotherapy through Blocking Glycolysis Metabolism and Inducing Pyroptosis
Nano Letters · 25.06.2025 · 25 (25) · 10053-10062
DOI: 10.1021/acs.nanolett.5c01811 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, online erschienen am 11.06.2025. Verfasst von Kuo He und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, Ch…. Hauptthemen laut MEDLINE: Pyroptosis, Glycolysis, Nanoparticles, Immunotherapy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Jilin Provincial Scientific and Technological Development Program, National Natural Science Foundation of China, Heilongjiang Touyan Innovation Team Program.
Abstract (Originalsprache)
Tumor metabolic reprogramming, particularly the Warburg effect, is crucial for rapid tumor growth and immune evasion. Lactate dehydrogenase A (LDHA), a key enzyme in tumor aerobic glycolysis, is overexpressed in tumors and is considered an effective therapeutic target. Sodium oxamate (SOM) is a classic LDHA inhibitor, but its poor cell permeability, low tumor killing effect, and ineffective immune activation limit its application. Herein, SOM nanoparticles (NPs) were prepared via a thin-film hydration method for amplified cancer immunotherapy. SOM NPs are efficiently taken up by tumor cells through endocytosis, releasing NH2COCOO- and Na+ ions, which cause osmotic pressure and oxidative stress, activating pyroptosis and immunogenic cell death (ICD) to initiate the immune response. Simultaneously, NH2COCOO- blocks glycolysis of tumor cells, resulting in inhibiting the proliferation, migration, and invasion and alleviating immunosuppression. This work will facilitate the application of SOM in tumor therapy and provide a new paradigm for glycolytic metabolism and pyroptosis-mediated tumor treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, 230026, China.
- Key Laboratory of Superlight Materials & Surface Technology of Ministry of Education, College of Material Sciences and Chemical Engineering, Harbin Engineering University, Harbin, 150001, China.
ORCID-Profile: Binbin Ding, Qi Meng, Ping'an Ma, Jun Lin
Förderung
- Jilin Provincial Scientific and Technological Development Program
- National Natural Science Foundation of China
- Heilongjiang Touyan Innovation Team Program
Zitieren
APA
He, K., Ding, B., Li, J., Meng, Q., Chen, H., Li, Z., Zhang, J., Ma, X., Shao, J., Ma, P., & Lin, J. (2025). Oxamate Nanoparticles for Enhanced Tumor Immunotherapy through Blocking Glycolysis Metabolism and Inducing Pyroptosis. Nano Letters, 25(25), 10053-10062. https://doi.org/10.1021/acs.nanolett.5c01811
Vancouver
He K, Ding B, Li J, Meng Q, Chen H, Li Z, et al. Oxamate Nanoparticles for Enhanced Tumor Immunotherapy through Blocking Glycolysis Metabolism and Inducing Pyroptosis. Nano Letters. 2025;25(25):10053-10062. doi:10.1021/acs.nanolett.5c01811
BibTeX
@article{He2025,
author = {He, Kuo and Ding, Binbin and Li, Jing and Meng, Qi and Chen, Hao and Li, Ziyao and Zhang, Jiashi and Ma, Xinyu and Shao, Junhao and Ma, Ping'an and Lin, Jun},
title = {Oxamate Nanoparticles for Enhanced Tumor Immunotherapy through Blocking Glycolysis Metabolism and Inducing Pyroptosis},
journal = {Nano Letters},
year = {2025},
volume = {25},
number = {25},
pages = {10053--10062},
doi = {10.1021/acs.nanolett.5c01811}
}
EUVIMED